Article Text

other Versions

PDF
Delay to angiography and outcomes following presentation with high-risk, non-ST elevation acute coronary syndromes (NSTE-ACS). Results from the Global Registry of Acute Coronary Events.
  1. Neil Swanson (b.n.swanson{at}talk21.com)
  1. Glenfield Hospital, United Kingdom
    1. Gilles Montalescot (gilles.montalescot{at}psl.ap-hop-paris.fr)
    1. Centre Hospitalier Universitaire Pitie-S, France
      1. Kim A Eagle (keagle{at}med.umich.edu)
      1. University of Michigan Cardiovascular Center, United States
        1. Shaun Goodman (goodmans{at}smh.toronto.on.ca)
        1. Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael’s Hospital, University of Toron, Canada
          1. Wei Huang (wei.huang{at}umassmed.edu)
          1. UMASS Medical School, Worcester, United States
            1. David Brieger (davidb{at}email.cs.nsw.gov.au)
            1. Concord Hospital, Sydney, Australia
              1. Gerard P Devlin (devling{at}waikatodhb.govt.nz)
              1. Waikato Hospital, New Zealand

                Abstract

                Objective: To test if delay-to-angiography (>72 h from admission) in patients presenting with high-risk non ST-elevation acute coronary syndromes (NSTE-ACS) is associated with adverse outcomes.

                Design: GRACE is a multinational registry of patients admitted with NSTE-ACS.

                Setting: 14 countries with varying healthcare systems.

                Patients: 23396 high-risk NSTE-ACS patients with complete initial data collection entered into GRACE between 1999 and 2006 were analysed.

                Interventions: Data were analysed according to delay-to-angiography and subsequent in-hospital or post-discharge adverse outcomes.

                Main outcome measures: Outcomes recorded included death, myocardial infarction, recurrent ischaemia, stroke, new heart failure and composite major adverse cardiovascular event (MACE) comprising death, cerebrovascular accident and myocardial infarction. Revascularisation procedures were recorded.

                Results: 10089 (43.1%) had no in-hospital angiography. Median delay-to-angiography was 46 h; 3680 (34%) patients waited >72 h. 9.3% waited >7 days before angiography. Patients waiting longest were more often older, diabetic, women, and have a history of heart failure, previous myocardial infarction, or hypertension. Recurrent in-hospital ischaemia (33% vs 22%), reinfarction (8.4% vs 5.0%), and heart failure (14% vs 9.1%) were more common with delayed angiography. Delayed angiography was associated with better outcomes than no angiography (MACE 18.9% v. 22.2%, p=0.015). MACE rates within six months of admission were higher with longer delay-to-angiography and highest of all with no angiography.

                Conclusions: High-risk NSTE-ACS is suboptimally managed with 43% not undergoing angiography. A third of those undergoing angiography are delayed >72 h. Longer delays were more likely with higher risk, sicker patients. These delays were associated with adverse outcomes at six months. Very long delay was associated with lower MACE, but not mortality, compared to conservative management.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.